LVH Predicts Worse Renal Outcomes in Hypertensive Patients

Share this article:

Left ventricular hypertrophy (LVH) is a significant predictor of adverse renal outcomes in hypertensive patients managed in a primary care setting, according to a study.

Consequently, clinicians should adopt systematic screening for LVH when assessing renal risk in hypertensive patients, investigators concluded.

A study led by Ernesto Paoletti, MD, of the IRCCS-Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy, looked at a data from 18,510 hypertensive patients for whom renal follow-up information was available. The baseline prevalence of chronic kidney disease (CKD) and LVH were 25.6% and 5.6%, respectively. During a five-year follow-up, 1.4% of patients with LVH progressed to end-stage renal disease requiring dialysis compared with 0.5% of subjects without LVH, the researchers reported online ahead of print in the American Journal of Hypertension. In addition, 25.6% of patients with LVH progressed from each stage of CKD to a more advanced stage compared with 17% without LVH, with 0.9% of patients with LVH and 0.4% of patients without LVH reaching stage 5.

After adjusting for multiple variables, LVH was associated with a significant 82% increased likelihood of progressing to dialysis and a 24% increased likelihood of progressing to a more advanced stage of CKD.

The study's findings highlight the need for systematic assessment of cardiac morphology and function in hypertensive patients with electrocardiography-proven LVH through the use of more accurate and reliable tools to identify patients at high risk of worsening renal function, Dr. Paoletti's team concluded.

Share this article:
You must be a registered member of RUN to post a comment.

More in Hypertension

Blood Pressure Stays Lower Longer in Fitter Men

Blood Pressure Stays Lower Longer in Fitter Men

Research suggests heart-healthy exercise may keep blood vessels more flexible.

Emergency Department Visits for Hypertension On the Rise

Emergency Department Visits for Hypertension On the Rise

But admission rates and in-hospital mortality for hypertension have decreased.

Renal Denervation Doesn't Lower Ambulatory Blood Pressure (BP)

Renal Denervation Doesn't Lower Ambulatory Blood Pressure (BP)

Second study shows denervation procedures may miss targets, may not meet threshold for effect.